Dodecanamide, 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)-, 98%, 1mg

4-Methoxy-5-methylpyridine-2-carbaldehyde, 95+%, 50mg

(R)-1-Boc-2,2-Dimethyl-4-hydroxymethyl-oxazolidine, 95.0%, 10g

4-((4-METHOXYBENZYL)(METHYL)AMINO)BUT-2-YN-1-OL, 95.0%, 250mg

4-Amino-N-(thiazol-2-yl)benzenesulfonamide, 95.0%, 25g

Volumetric flasks with glass stopper, class A Trapezoidal shape, 10 ml, 10/19, 2 Piece(s)

(1H-INDAZOL-7-YL)METHANAMINE, 95%, 5g

5-Chloropyrazine-2-carboxamide, 95.0%, 25g

tert-Butyl (3aR,6aR)-2-phenylhexahydropyrrolo[3,4-c]pyrrole-3a(1H)-carboxylate, 95%, 250mg

5,10,15,20-Tetrakis(pentafluorophenyl)porphyrin>95.0%(HPLC)100mg

1-(3-Amino-2,6-dichloropyridin-4-yl)ethanone, 97.0%, 1g

Ethyl 5-amino-2-methylthiazole-4-carboxylate, 95.0%, 25g

(2,2-Dimethyl-1,3-dioxan-5-yl)methanol, 98.0%, 5g